<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Hepatic hemangioendothelioma":1,
"consumptive hypothyroidism":1,
"type 3 iodothyronine deiodinase":1,
"Graves’ disease":2,
"hypoparathyroidism":3,
"thyroid cancer":29,
"thyroidectomy":12,
"thyrotoxicosis":1,
"MTC":1,
"medullary thyroid carcinoma":7,
"miR-183":1,
"miR-375":1,
"miR-9*":1,
"carcinoma":4,
"local":1,
"neoplasm recurrence":1,
"papillary":5,
"thyroid neoplasm":1,
"fine needle aspiration":7,
"liquid-based cytology":2,
"reproducibility":1,
"risk of malignancy":2,
"the Bethesda system for reporting thyroid cytopathology":1,
"thyroid":25,
"metastases":3,
"neck dissection":4,
"surgeon-performed ultrasound":1,
"locoregional neoplasm recurrences":1,
"lymphatic metastasis":4,
"papillary thyroid carcinoma":22,
"autoimmune thyroiditis":1,
"papillary carcinomas":1,
"thyroid nodules":2,
"clinicopathological characteristics":1,
"incidental":1,
"nonincidental":1,
"papillary thyroid microcarcinoma":2,
"surgical treatment":1,
"Histone methylation":1,
"Neuroendocrine tumors":1,
"Pancreatic islet":1,
"Parathyroid":1,
"Pituitary":1,
"Tumors":1,
"Anaplastic":2,
"BRAF":4,
"Follicular":2,
"PAX8-PPARG":1,
"RAS":1,
"1,4-Michael addition mechanism":1,
"Apurinic sites in DNA":1,
"Cancer prevention by N-acetylcysteine and resveratrol":1,
"Carcinogenicity of 4-hydroxyestrogens":1,
"Cytochrome P4501B1":1,
"Depurinating PAH–DNA adducts":1,
"Depurinating estrogen–DNA adducts":1,
"Estrogen-3,4-quinones":1,
"Genotoxicity of estrogens":1,
"Hormonal carcinogenesis":1,
"Imbalance of estrogen homeostasis":1,
"Mutations by error-prone repair":1,
"Nonhormonal carcinogenesis":1,
"PAH diol epoxides":1,
"PAH radical cations":1,
"Preneoplastic mutations":1,
"ATM":1,
"FOXE1":1,
"genetic susceptibility":1,
"radiation-induced cancer":1,
"Colon cancer":1,
"prognosis":7,
"recurrence risk":1,
"tumour budding":1,
"Laryngeal chondrosarcoma":1,
"cricotracheal resection and anastomosis":1,
"endoscopic resection":1,
"open neck partial laryngectomy":1,
"BREAST CANCER 1 EARLY ONSET (BRCA1)":1,
"GROWTH":1,
"HCC":2,
"INFLAMMATION":1,
"NO-TUMOR HEPATITIS/CIRRHOTIC TISSUES (HBV OR HCV INFECTION)":1,
"cytopathology":1,
"fine-needle aspiration":4,
"fine-needle capillary":1,
"thyroid nodule":10,
"inflammatory microenvironment":1,
"thyroid carcinomas":1,
"tumor-associated macrophages":1,
"tumor-infiltrating lymphocytes":1,
"TTF-1":2,
"chemotherapy":4,
"immunohistochemistry":7,
"lung cancer":1,
"p40":1,
"survival":3,
"fine-needle cytology":1,
"mantel zone lymphoma":1,
"microRNAs":1,
"primary thyroid lymphoma":1,
"Clinical trials":2,
"Harmonic scalpel":1,
"Hemostasis":1,
"LigaSure":1,
"ET(A)R":1,
"ET-1":1,
"Endothelin 1":1,
"Endothelin receptor A":1,
"Robotic thyroidectomy":2,
"endoscopic thyroidectomy":2,
"gasless unilateral axillary approach":1,
"gasless unilateral axillo-breast approach":1,
"Evidence-based medicine":1,
"Lung":1,
"Metastasis":6,
"Minimal IHC panel":1,
"Supraclavicular lymph node":1,
"Gastric adenocarcinoma":1,
"NQO1":1,
"Survival analysis":2,
"PTC":1,
"PTmC":1,
"microcarcinoma":1,
"central lymph node metastasis":1,
"central neck dissection":3,
"intraoperative assessment":1,
"Hürthle cells":1,
"cytology":3,
"fine-needle aspirate":1,
"oncocytes":1,
"Androgenic alopecia (AA)":1,
"National Health Insurance system":1,
"Population-based study":1,
"Atrophic renal parenchyma-like tumor":1,
"Comparative genomic hybridization":1,
"HUMARA":1,
"Kidney":2,
"Thyroid-like renal tumor":1,
"adolescents":1,
"cancer disparities":1,
"health care reform":1,
"health insurance":1,
"young adults":1,
"Medicare":1,
"bilateral vocal fold paralysis":1,
"epidemiology":2,
"incidence":5,
"unilateral vocal fold paralysis":1,
"vocal fold paralysis":1,
"head and neck cancer":3,
"hypothyroidism":2,
"radiotherapy":4,
"brachial plexus injury":1,
"hemorrhage":1,
"hoarseness":1,
"hypocalcemia":3,
"length of stay":1,
"operative time":1,
"quality of life":3,
"recurrent laryngeal nerve injury":1,
"robotic surgery":1,
"Fine needle aspiration biopsy":2,
"Image-guided intervention":1,
"Specimen adequacy":1,
"Generalized myasthenia gravis":1,
"Ocular myasthenia gravis":1,
"T follicular helper cells":1,
"Thymoma":1,
"Thymus":1,
"Frailty":1,
"Intellectual disability":1,
"Mental health":1,
"Multimorbidity":1,
"Galectin":1,
"Galectin 1":1,
"Galectin 3":1,
"corticotropinoma":1,
"endocrine tumor":1,
"p27":1,
"pituitary tumor":1,
"Cancer":5,
"Mortality":2,
"Mortalité":1,
"Registre":1,
"Registry":1,
"Tendance":1,
"Trends":1,
"AYA":1,
"adolescent":1,
"second cancer":1,
"young adult":2,
"ABCG2/BCRP gene":1,
"EMT inducer genes":1,
"papillary thyroid carcinoma cell line (TPC-1)":1,
"Virtual Touch tissue imaging":1,
"acoustic radiation force impulse":1,
"superficial structures":4,
"ultrasound elastography":1,
"computed tomography":1,
"fine-needle biopsy":1,
"hemangioma":1,
"sonography":3,
"vascular malformations":1,
"Anaplastic thyroid cancer":5,
"End of life":1,
"Medical ethics":1,
"Palliative care":2,
"Ovarian cancer":1,
"review":2,
"sorafenib":2,
"targeted therapeutics":1,
"treatment":3,
"MEK inhibitor":1,
"genetically-engineered mouse model":1,
"vemurafenib":2,
"Follicular thyroid cancer":3,
"Gene expression":1,
"Real-time polymerase chain reaction":1,
"Goiter":2,
"Sjögren’s syndrome":1,
"autoimmune diseases":1,
"long-term follow-up":1,
"neoplasia":1,
"non-Hodgkin’s lymphoma":1,
"kidney transplantation":1,
"non-Hodgkin lymphoma":2,
"post-transplant malignancy":1,
"Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography":1,
"papillary carcinoma thyroid":1,
"subcutaneous metastasis":1,
"unknown primary":1,
"Breast neoplasms":2,
"Second primary neoplasms":1,
"Thyroid neoplasms":5,
"Korea":1,
"Neoplasms":2,
"Prevalence":1,
"Heteogeneity":1,
"Skin neoplasms":1,
"Subtype":1,
"Thyroglossal duct cyst":1,
"thyroid papillary carcinoma":1,
"health disparities":1,
"poverty":1,
"socioeconomic status":1,
"surveillance":1,
"Lymph node metastasis":2,
"Lymphatic invasion":1,
"Recurrence":2,
"Thyroid cancer, papillary":2,
"Tumor sprouting":1,
"Recurrent laryngeal nerve":1,
"Thyroid hormone":2,
"Carcinoma, squamous cell":1,
"Neoplasm recurrence, local":1,
"Thyroid gland":3,
"fine-needle aspiration biopsy":1,
"smooth muscle tumor":1,
"thyroid leiomyosarcoma":1,
"total thyroidectomy":3,
"esophageal cancer":2,
"microlymphatic vessel density":1,
"vascular endothelial growth factor receptor-3":1,
"vascular endothelial growth factor-C":1,
"Adenomyoepithelial adenosis":1,
"adenomyoepithelioma":1,
"adenosis":1,
"breast":3,
"ultrasonography":6,
"Occult follicular thyroid carcinoma":1,
"spinal cord compression":1,
"spinal metastasis":1,
"Tyrosine-kinase inhibitor":1,
"calcitonin":4,
"sporadic":1,
"Ovary cancer":1,
"EGF-TM7":1,
"EMR2":1,
"G-protein coupled receptor":1,
"Anxa4":1,
"Biomarker":2,
"Drug resistance":1,
"Breast cancer":2,
"lipid-rich carcinoma":1,
"male":1,
"association":1,
"hashimoto's thyroiditis":1,
"histopathology":1,
"medullary carcinoma of thyroid":1,
"Thyroid follicular carcinoma":1,
"AMPK":1,
"NIS":1,
"Warburg effect":1,
"mTOR":1,
"metformin":2,
"Cabozantinib":1,
"Vandetanib":2,
"bilateral axillo-breast approach":1,
"endoscopy":1,
"gasless transaxillary approach":1,
"CD99":1,
"EWSR-FLI1":1,
"small cell tumor":1,
"thyroid carcinoma":5,
"malignancy":3,
"ultrasound":4,
"aggressiveness":1,
"solid":1,
"variant":1,
"multiple endocrine neoplasia type 1":1,
"parathyroid, carcinoma, ectopic location":1,
"Carcinoïd":1,
"Carcinoïde":1,
"Flush":1,
"Mastocytose":1,
"Mastocytosis":1,
"Pheochromocytoma":1,
"Phéochromocytome":1,
"Vipoma":1,
"Vipome":1,
"c-Kit":1,
"Cancer risk":2,
"Heterotopic ossification":1,
"Monte Carlo simulation":1,
"CT–CBCT registration":1,
"Deformable algorithm":1,
"Laryngectomy":1,
"complications":1,
"aggressive fibromatosis":1,
"robotics":1,
"genetic association study":1,
"genetic predisposition":1,
"nonmedullary thyroid carcinoma":1,
"single nucleotide polymorphisms":1,
"thyroid vein":1,
"adenocarcinoma":3,
"endometrium":1,
"immunohistohemistry":1,
"medullary carcinoma":1,
"neuroendocrine tumor":1,
"primary extraskeletal Ewing family tumors":1,
"small cell carcinoma":1,
"Elastography":1,
"Gray-scale ultrasound":1,
"Level of experience":1,
"chemoradiation":1,
"exercise":1,
"swallowing":1,
"tongue strength":1,
"Behcet' s disease":1,
"hematologic malignancy":1,
"malignant solid neoplasm":1,
"GST-T1":1,
"Podoplanin":1,
"laryngeal carcinoma":1,
"squamous cell carcinoma":2,
"arsenic":1,
"cannabinoids":1,
"chloroquine":1,
"lithium":1,
"nelfinavir":1,
"repositioning therapy":1,
"statins":1,
"valproic acid":1,
"Pre-operative surveillance":1,
"Staging":1,
"immunocytochemistry":1,
"malignancies":1,
"pediatric patients":1,
"thyroid lesions":1,
"cost analysis":1,
"cost of cancer care":1,
"economic analysis":1,
"Cyclin D1":1,
"Intratumoral heterogeneity":1,
"Ki-67":2,
"Linage-specific markers":1,
"Thymidylate synthase":1,
"FISH":1,
"FNA":4,
"PAX8/PPARg":1,
"RET/PTC":2,
"Lung carcinoma":1,
"advanced cancer":1,
"hypogonadism":1,
"symptom management":1,
"Crizotinib":1,
"EML4-ALK fusion protein":1,
"Lung neoplasms":2,
"Non-small-cell lung":1,
"BRAF mutation":3,
"Bethesda System for Reporting Thyroid Cytopathology":2,
"atypia of undetermined significance":2,
"follicular lesion of undetermined significance":2,
"Apoptosis":1,
"Migration":1,
"miRNA":1,
"Cell apoptosis":1,
"Cell growth":1,
"Cell migration":1,
"MiR-129-5p":1,
"REarranged during Transfection proto-oncogene":1,
"Adenoid cystic carcinoma":1,
"Napsin A":1,
"Thyroid transcription factor 1":1,
"Endocrine gland neoplasms":1,
"Long noncoding RNA":1,
"Oncogenes":1,
"Small untranslated RNA":1,
"Tumor suppressor genes":1,
"differentiated thyroid carcinoma":2,
"juvenile":1,
"outcome":1,
"radioiodine therapy":1,
"Bocio":1,
"Cervicotomy":1,
"Cervicotomía":1,
"Esternotomía":1,
"Goitre":1,
"Mediastinal":1,
"Mediastino":1,
"Sternotomy":1,
"Adverse events":1,
"Dose reduction":1,
"Drug interruptions":1,
"Overall survival":1,
"Time to failure":1,
"Anaplastic thyroid carcinoma":1,
"CHN":1,
"EWSR1":1,
"Extraskeletal myxoid chondrosarcoma":2,
"NR4A3":1,
"TAF15":1,
"TCF12":1,
"2-dimensional sonography":1,
"3-dimensional sonography":1,
"extrathyroidal extension":1,
"tumor staging":1,
"Fluorodeoxyglucose":1,
"TTF1":1,
"lung cancer prognosis":1,
"myoepithelioma":1,
"palate":1,
"salivary gland":1,
"soft tissue neoplasms":1,
"Autopsy":1,
"Latent Carcinoma":1,
"Distant metastases":1,
"Follicular adenocarcinoma":1,
"Hurthle cell thyroid cancer":1,
"Iodine":1,
"Bronchogenic cyst":1,
"laser ablation":2,
"microwave":1,
"radiofrequency ablation":2,
"thermal ablation":1,
"thyroid ultrasound":2,
"Micro papillary cancer":1,
"papillary thyroid micro cancer":1,
"thyroid micro cancer":1,
"BRAF V600E":2,
"Nuclear medicine-imaging":1,
"pathology-thyroid cytology":1,
"thyroid cancer-clinical":1,
"thyroid cancer-genetics":1,
"CXCR1":1,
"EGFR":3,
"GPER1":1,
"Cancer survivors":1,
"Children brain tumors":1,
"Endocrinopathy":1,
"Late effects":1,
"Metabolic complications":1,
"Thyroidectomies":1,
"Population study":1,
"Second malignancy":1,
"MELK":1,
"PCR":1,
"tumor marker":1,
"TBSRTC criteria":1,
"MEN2":1,
"MIVAT":1,
"RET":1,
"medullary thyroid cancer":3,
"thyroglobulin":2,
"meta-analysis":1,
"systematic review":1,
"thyroid stimulating hormone":1,
"vascular endothelial growth factor":2,
"skip":1,
"univariate analysis":1,
"cytomorphology":1,
"diffuse sclerosing variant":1,
"fine needle aspiration cytology":4,
"hobnail pattern":1,
"mirror ball":1,
"Thy3":1,
"Tir3":1,
"follicular lesions":2,
"indeterminate cytology":2,
"systems for reporting thyroid cytopathology":1,
"thyroid tumours":1,
"follicular neoplasia":1,
"indeterminate categories":1,
"Bethesda system":1,
"Hürthle cell":1,
"thyroid cytopathology":1,
"thyroid neoplasia":1,
"mapping":1,
"Injured recurrent laryngeal nerve":1,
"direct nerve anastomosis":1,
"immediate nerve anastomosis":1,
"diagnosis":2,
"papillary thyroid cancer":4,
"(18)FDG-PET":1,
"Malignant head and neck paraganglioma":1,
"Octreoscan":1,
"SDHx mutation":1,
"CD-44":1,
"HBME-1":2,
"galectin-3":1,
"cytodiagnosis":1,
"follicular variant":1,
"Consulta de alta resolución":1,
"Diagnostic efficiency":1,
"Ecografía tiroidea":1,
"Eficiencia diagnóstica":1,
"High-resolution clinic":1,
"Nódulo tiroideo":1,
"Differentiated thyroid cancer":4,
"Molecular biology":1,
"PAX8/PPARγ":1,
"melt curve analysis":1,
"mutation analysis":1,
"cytokeratin-19":1,
"fine needle aspiration, FNA cytology":1,
"follicular neoplasms":1,
"Differentiation therapy":1,
"Radioiodine treatment":1,
"Primary synovial sarcoma":1,
"anti-CEA antibodies":1,
"b-raf inhibitors":1,
"histone deacetylase inhibitors":1,
"kinase inhibitors":1,
"thyroid cancer therapy":1,
"Genetic":1,
"SNPs":1,
"risk prediction":1,
"incidental thyroid nodule":2,
"incidentaloma":1,
"Hashimoto thyroiditis":1,
"autoimmunity":1,
"tumor immunity":1,
"MicroRNA-21":1,
"Programmed cell death 4":1,
"TPC-1":1,
"Incidental findings":1,
"MRI":1,
"cyclo-oxygenase-2":1,
"matrix metalloproteinase-9":1,
"Energy-Based Device":1,
"Harmonic Focus":1,
"Small Jaw":1,
"comparison":1,
"open thyroidectomy":1,
"CCNA2":1,
"HMGA2":1,
"Pituitary adenoma":1,
"microRNA":1,
"Antiangiogenic":1,
"Chondrosarcoma":1,
"Sarcoma":1,
"Sunitinib":1,
"KRAS":1,
"Lung adenocarcinoma":2,
"MUC5AC":1,
"MUC5B":1,
"Terminal respiratory unit (TRU)":1,
"Thyroid bed":1,
"Papanicolaou Society of Cytopathology":1,
"guidelines":2,
"pancreas":2,
"Appropriateness Criteria":1,
"Radiotherapy thyroid cancer":1,
"Well differentiated thyroid cancer":1,
"CD4−CD8−T cells":1,
"Treg":1,
"tumor immunology":1,
"Adrenal gland":1,
"Pituitary gland":1,
"VE1":1,
"Hypopharyngeal cancers":1,
"Total laryngectomy":1,
"Genetic testing":1,
"Molecular markers":1,
"Prophylactic central compartment neck dissection":1,
"Advanced thyroid cancer":1,
"Medical therapy":1,
"Medullary and differentiated thyroid cancer":1,
"Targeted therapy":3,
"Overdiagnosis":1,
"RIA":1,
"Radioiodine ablation":1,
"Risk stratification":2,
"Neuroendocrine":1,
"Neuroendocrine liver metastases":1,
"Nonfunctional":1,
"PanNET":1,
"biopsy":2,
"nodule":1,
"acoustic radiation force impulse imaging":1,
"pneumonectomy":1,
"stomach neoplasms":1,
"gastrointestinal bleeding":1,
"gastrointestinalis vérzés":1,
"intestinal metastasis":1,
"pajzsmirigy":1,
"primary thyroid angiosarcoma":1,
"primer angiosarcoma":1,
"vékonybéláttét":1,
"Robotic":3,
"Transaxillary":1,
"Remote access":1,
"Papillary carcinoma":2,
"Sistrunk operation":1,
"Thyroglossal duct cysts":1,
"131-iodine":1,
"Recombinant human TSH":2,
"Thyroid hormones":1,
"Atypia of uncertain significance/follicular lesion of uncertain significance":1,
"Follicular neoplasm/suspicious for follicular neoplasm":1,
"Genetic mutations in thyroid cancer":1,
"Immunohistochemical tests":1,
"Molecular diagnosis for thyroid nodules":1,
"Suspicious for malignant cells":1,
"TSH":1,
"Thyrotropin":1,
"Radioactive iodine":2,
"Radioiodine":2,
"Response to therapy":1,
"MEN type 2":1,
"Pathophysiology":1,
"Modified radical neck dissection":1,
"Pediatric thyroid cancer":1,
"Thyroid cancer surgery":1,
"Endoscopic":1,
"Minimally invasive":1,
"Thyroid surgery":1,
"Fatigue":1,
"Survivorship":1,
"Vitality":1,
"Cervical lymph nodes":1,
"Cervical re-operation":1,
"Ethanol injection":1,
"Ghrelin":1,
"tumor progression":1,
"alpha-actinin-4":1,
"infiltrative margin":1,
"preoperative recurrent laryngeal nerve paralysis":1,
"pushing margin":1,
"epidermal growth factor receptor mutation":1,
"small biopsy":1,
"Thyrotropin Alfa":1,
"Diffuse":1,
"anaplastic carcinoma":1,
"paclitaxel":1,
"skin metastasis":1,
"thoracic":1,
"features":1,
"thyroid-like follicular carcinoma of the kidney":1,
"celecoxib":1,
"doxorubicin":1,
"xenograft tumor":1,
"CD31":1,
"epithelioid angiosarcoma":1,
"factor VIII-related antigen":1,
"spine":1,
"vertebral tumor":1,
"Personalized therapy":1,
"XL184":1,
"Classification":1,
"Histologic types":1,
"Tall cell features":1,
"Proto-oncogene proteins B-raf":1,
"Thyroid cancer, anaplastic":1,
"ethanol ablation":1,
"Epidermal growth factor mutation":1,
"Erlotinib":1,
"Intratumoural heterogeneity":1,
"Metastatic thyroid carcinoma":1,
"Poorly differentiated carcinoma":1,
"Poorly differentiated thyroid carcinoma":1,
"Tyrosine kinase inhibitors":1,
"Autoimmune thyroid disease":1,
"Immunometric assay":1,
"Choroid":1,
"Phalanx":1,
"Non-small cell lung carcinoma":1,
"Follicular carcinoma":1,
"renal cell carcinoma":1,
"solitary fibrous tumor":1,
"Thyroid malignancy":1,
"Hypopharynx":1,
"parapharyngeal space":1,
"Clinical significance":1,
"Glucagon-like peptide-1 receptor":1,
"Incretin-based therapy":1,
"Twist1":1,
"Twist1 degradation":1,
"lung metastasis":1,
"tamoxifen":1,
"glioblastoma multiforme (GBM)":1,
"thyroid hormones (TH)":1,
"TGF-β1":1,
"PKM2":1,
"cancer metabolism":1,
"glycolysis":1,
"pyruvate kinase":1,
"Thyroid Disorders":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2014年第2季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
